Search
-
NewBarcelona Science Park, a strategic hub for public R&D&i of excellence
2021 was a year full of challenges and milestones achieved for public research groups and institutes working at the Barcelona Science Park
-
NewAseBio closes out year with 1,000 lines of research registered
86.6% of studies under way focus on improving people’s health and nearly 14% on protecting the planet. Of all these innovations, 203 are already available on the market or ready for exploitation
-
NewOxolife receives a 2.4M€ grant to develop a new treatment for infertility related to polyc...
Oxolife, in collaboration with Cordoba’s University, will advance from preclinical to phase II clinical trials in the next 2 years
-
NewORYZON presents final data from Phase IIa ALICE trial in unfit AML patients with first-lin...
Clinical efficacy signals were robust, with an objective response rate (ORR) of 81%; of these, 64% were complete remissions (14 CR/CRi) and 36% partial remissions (8 PR)
-
NewHow a biotech firm from Granada found its place in the competitive international market
LentiStem Biotech, a spin-off that has just celebrated its sixth anniversary, decided to focus on CAR-T therapies, developing technology that instead of competing builds synergies
-
NewThis was the Health Hackathon 2022
Last Thursday, November 24, the Ramón y Cajal Hospital in Madrid hosted the Health Hackathon 2022
-
NewPharmaMar leads the ONCOLIBERYX consortium together with four research centers to develop ...
The project, given the necessity for public-private collaboration projects, approved by the Ministry of Science and Innovation, has a financing of €3.49 million from funds from the Recovery
-
NewPeaches Biotech receives financial approval from the Ministry of Science and Innovation fo...
The State Research Agency (AEI) of the Ministry of Science and Innovation approves financing for two Peaches Biotech projects in its call for public-private collaboration The chosen investigations are
-
NewBiotechnology, an industry that will make the difference after COP 27
AseBio is organising a bio breakfast to discuss the main conclusions of the summit and the Green Innovation Forum and to look at the steps to be taken to better position our industry in the 2030
-
NewClément Destoumieux, CEO of medmesafe will attend the Health Hackathon 2022
On November 24, the Health Hackathon will be held at the Ramón y Cajal Hospital in Madrid
-
NewNuevos estudios de genética preventiva
Dreamgenics acaba de lanzar al mercado cuatro nuevos estudios genéticos preventivos bajo la denominación DG Preventive que se unen a su cartera de estudios genéticos diagnósticos
-
NewIQS y el Institut Borja de Bioètica (IBB) lanzan el Posgrado en Ética Medioambiental
IQS y el Institut Borja de Bioètica (IBB) lanzan el Posgrado en Ética Medioambiental, centrado en abordar las problemáticas éticas asociadas a la gestión medioambiental
-
New‘Globolizados: Road trip’: a solidarity challenge to support associations and patients wit...
The 'Globolizados' solidarity campaign, developed by Janssen Spain with the social support of the Spanish Society of Haematology and Haemotherapy (SEHH), reaches its seventh edition with the online
-
NewBIOLAN Awarded as connected 4.0 SME in the IV Edition of the National Industry 4.0 Awards ...
Estos premios reconocen el esfuerzo y el mérito de las empresas industriales españolas en el ámbito de la digitalización
-
NewBiotechnology solutions emerge as way to tackle climate and energy challenges
AseBio and FUNDECYT-PCTEx held the fifth Green Innovation Forum in Mérida, Extremadura Over 300 experts from the Spanish biotechnology sector met to drive a new model for economic growth based on the
-
NewValue-based medicine and Risk Sharing Agreement
We have witnessed major advances in biotechnology and synthetic biology that are likely to result in the emergence of new therapeutic treatments for diseases that until recently were either poorly
-
NewBrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeop...
The novel drug could cure neurodegenerative diseases such as Amyotrophic Lateral Sclerosis
-
NewLos desafíos de salud global de este siglo marcan la entrega de la III edición de los Inte...
Estas han sido las temáticas sobre las que han versado la mayor parte de las candidaturas de esta edición de los galardones
-
NewGroup of experts proposes actions to boost use of new technologies in biotechnology sector
In Madrid, AseBio and ASD presented a document with the main conclusions on the state of new technologies in the industry. One of the proposals is to train professionals and delve deeper into a
-
NewORYZON announces FDA clearance of IND to initiate a collaborative Phase II basket study wi...
Collaborative study with Fox Chase Cancer Center (FCCC)
-
NewMinoryx y Neuraxpharm anuncian una alianza estratégica para ofrecer una nueva terapia a lo...
Ambas compañías han firmado un acuerdo de licencia por los derechos europeos de leriglitazona